It is known that several second messengers, such as Ca 2+ or cAMP, play important roles in the intracellular pathway of electrolyte secretion in tracheal submucosal gland. However, the participation of cGMP, and therefore nitric oxide (NO), is not well understood. To investigate the physiological role of NO, we first examined whether tracheal glands can synthesize NO in response to acetylcholine (ACh), and then whether endogenous NO has some effects on the ACh-triggered ionic currents. From the experiments using the NO-specific fluorescent indicator 4,5-diaminofluorescein diacetate salt (DAF-2DA), we found that a physiologically relevant low dose of ACh (100 nM) stimulated the endogenous NO synthesis and it was almost completely suppressed in the presence of the non-specific NO synthase (NOS) inhibitor Nω-Nitro-L-arginine
Introduction
The airway mucosa is always exposed to various microbes or micro inhalated foreign bodies (1, 2) , but the airway is protected against infection. This is because both a non-specific and a specific defense system always work in the airway. The airway submucosal gland secretes mucin, various enzyme proteins, and electrolytes (therefore, water), which serve as a nonspecific airway defense mechanism.
Moreover, the submucosal gland secretes immunoglobulins to neutralize and/or eliminate microbes or foreign substances, serving as a specific airway defense mechanism (2) . Concerning electrolyte or water secretion, it is well known that the airway surface liquid is regulated quantitatively (the volume of mucous or water) (3, 4) and qualitatively (osmolality or pH, etc) (5) (6) (7) (8) in order to maintain a suitable environment for the airway mucosal defense systems. Cystic Fibrosis (CF) is caused by mutations of CF transmembrane conductance regulator (CFTR), which acts as a cAMP-activated chloride channel in the airway epithelium (9) . Mutations of this chloride channel alter the transport of chloride and associated liquid, resulting in an impairment of the lung defenses (8) . This pathogenesis reveals that the airway chloride secretion plays a very important role in the airway defense. Because human airway epithelium is likely to be primarily absorptive (1, 10, 11), a major fraction of the airway fluid seems to be derived from the submucosal glands (12, 13) . We have reported that human, feline and swine tracheal gland acinar cells generated ionic currents in response to relative low doses of cholinergic and α-adrenergic stimuli, and that the currents were activated by the intracellular Ca 2+ concentration ([Ca 2+ ] i ) raised by these neurotransmitters 3 submucosal glands (20) . But there is hardly any information about the physiological role of NO in airway electrolyte secretion.
Here, we investigated whether tracheal glands synthesize NO when stimulated by acetylcholine (ACh) and whether endogenous NO is involved in the physiological signaling pathway in tracheal gland secretion. Our results suggest that ACh or [Ca 2+ ] i dependent NO/cGMP/cGK signaling is involved in the physiological signaling pathway in the airway electrolyte secretion and that endogenous NO potentiates the ACh induced Cl -secretion.
Materials and Methods

Cell preparation
Swine tracheas were obtained at a local slaughterhouse immediately after the animals had been sacrificed and were transported to our laboratory in an ice-cold extracellular solution.
The external surface of the trachea was cleaned of fat and connective tissues, and cut into rings 3-4 cm long. The posterior (membranous) strip of the tracheal wall was then excised longitudinally, leaving attached to both sides about 1 cm width of the cartilaginous portion, and was fixed by pins in the extracellular solution with the external wall side up. The outermost layer and thick smooth muscle layer were carefully removed. The submucosal gland could then be easily distinguished from the surrounding connective tissue under a stereoscopic microscope with the light shed horizontally. Fresh, unstained submucosal glands were isolated using two pairs of tweezers and microscissors (14) (15) (16) (17) 26 ). The isolated glands were further dispersed enzymatically by incubating them with enzyme solution containing collagenase (200 U/ml), DL-dithiothreitol (0.31 mg/ml), and trypsin inhibitor (1 mg/ml) for 30 min at 37 °C. After dispersion and a wash with centrifugation at 180 x g the cells were resuspended in a standard extracellular solution until use. Although DTT is a strong reducing reagent that interacts with free radicals, because DTT is not stable in a standard ringer solution and was washed out repeatedly before use, the artifacts of DTT on the synthesis and the biological activity of NO can be practically ignored in our study.
Intracellular NO imaging with DAF-2DA
A highly specific fluorescent NO indicator 4,5-diaminofluorescein (DAF-2), is known to be useful to estimate the amount of NO produced in the cytosol (27). The diacetate salt DAF-2DA is membrane permeable and is soon hydrolyzed at the ester bonds by the intracellular esterase, resulting in the membrane impermeable and relatively non-fluorescent compound DAF-2. In the presence of oxygen, NO combines with DAF-2 and forms the highly fluorescent triazolofluorescein DAF-2T. Peak excitation and emission wavelengths for DAF-2T occur at 495 and 515 nm, respectively. The fluorescence intensity shows a linear correlation with the concentration of DAF-2T, which is in parallel with the cellular production of NO. In the present study, freshly isolated swine tracheal glands were preloaded with 10 µM DAF-2DA for 40 min or more at 37 °C so that the cytosol was saturated with DAF-2. At the beginning of each experiment, we adjusted the fluorescent intensity so that little fluorescent would be observed in control-and non-stimulated conditions. All experiments were carried out under the same conditions. In order to prevent the fluorescence signaling from becoming attenuated, the fluorescence intensity was measured for 5 sec every 5 or 10 min. The solutions were the same compositions as used in the patch-clamp experiments (see below), and were superfused over the cells continuously at 2 ml/min at 37 °C with or without 100 nM of ACh. Then, the solutions were gassed with 100% O 2 during the measurements. The gray levels in the areas of gland cells in the captured microfluorographs were determined by a digital image processor (NIH Image 1.62 / Macintosh G3 /100 AV). In this way, we detected the increase in the amount of intracellular NO per unit area of gland cells at each measurement time. NO productions were shown as a fold increases over the basal fluorescent intensity.
Electrical recordings
Ionic currents were measured with a patch-clamp amplifier (EPC9; HEKA Electronic, Lambrecht / Pfalz, Germany), low-pass filtered at 2.9 kHz, and monitored on both a built-in software oscilloscope and a thermal pen recorder (RECTI-HORIZ-8K; Nippondenki Sanei, Tokyo, Japan). Patch pipettes were made of borosilicate glass capillary with an outer diameter of 1.5 mm using a vertical puller (PP-83; Narishige Scientific Instruments, Tokyo, Japan), and had a tip resistance of 2 to 6 MΩ. The junction potential between the patch-pipette and bath solution was nulled by the amplifier circuitry. After establishing a high-resistance (1 GΩ), tight seal, the whole cell configuration was obtained by rupturing the patch membrane with negative pressure applied to the pipette tip. Membrane currents were monitored at two different holding potentials 
Quantification Procedure
The procedure to estimate the ionic responses was also applied in our previous reports The effect of L-NAME on the ACh-stimulated response was estimated by comparing just before and after treatment with L-NAME and was expressed as a percentage of the pretreatment control values.
%I mean (ACh+L-NAME) = {I mean (ACh+L-NAME)/ I mean (ACh)} x 100 (%)
The effect of L-arginine on the responses induced by both ACh and L-NAME was expressed as a percentage of I mean (ACh+L-NAME).
%I mean (ACh+L-NAME+L-arginine) = {I mean (ACh+L-NAME+L-arginine)/ I mean (ACh+L-NAME)} x 100 (%)
In bar graphs, %I mean (ACh+L-NAME+L-arginine) was modified to express the percentage of I mean (ACh+L-NAME+L-arginine) to I mean (ACh). In some experiments, L-NAME was replaced by 7-NI, and L-arginine was replaced by NOC-5.
Statistics
The data were expressed as means ± standard error; n is the number of experiments on different cells. Data were analyzed by Wilcoxon's signed rank test, and significance was accepted at P< 0.05 and indicated by asterisks in all figures.
Reagents
Hepes and NOC-5 were purchased from Dojindo Co. Ltd. (Kumamoto, Japan).
DAF-2DA was from Daiichi Pure Chemicals Co. Ltd. (Ibaraki, Japan).
Collagenase was from
Wako Pure Chemicals (Osaka, Japan) and KT-5823 and Rp-8-Br-cGMP were from Calbiochem (La Jolla, CA). All other chemicals used were purchased from Sigma (St. Louis, MO). Figure 1E ). These findings demonstrate that ACh is able to increase endogenous NO synthesis and that the elevation in [Ca 2+ ] i plays a pivotal role in the NO synthesis.
Results
ACh
Effects of NOS inhibitors on NO synthesis
Among the three isoforms of NOS, nNOS and eNOS are known to be constitutively ] i (22) . Therefore, we next investigated the involvement of NOS in tracheal gland NO synthesis. We used two different types of NOS inhibitors, Nω-Nitro-L-arginine Methyl Ester Hydrochloride (L-NAME) and 7-Nitroindazole (7-NI). L-NAME is a nonspecific NOS inhibitor, and 7-NI is a specific nNOS inhibitor. Both of these inhibitors competitively block the binding of NOS with L-arginine, and these inhibitory effects are reversible by the subsequent addition of L-arginine (33) . Before ACh stimulation, cells were preloaded with 1 mM of L-NAME or 7-NI for 1 hr. In the presence of L-NAME, the addition of ACh (100 nM) caused no obvious increase in the fluorescence intensity.
However, the intensity distinctly increased after the subsequent addition of L-arginine (1 mM) ( Figure 2A ). In the presence of 7-NI, ACh (100 nM) made no obvious increase in the fluorescence intensity, but after the subsequent addition of L-arginine (1mM), the intensity rapidly and greatly increased ( Figure 2B ). These findings suggested that the activation of NOS, especially nNOS, would be essential to the ACh-stimulated NO synthesis in tracheal glands.
Effects of NOS inhibitors on ACh-induced ionic currents
We investigated whether the endogenous NO has some effects on the ACh evoked ionic currents. Because endogenous NO synthesis was almost completely suppressed in the presence of NOS inhibitors ( Figure 2 ), we could observe the ACh-evoked ionic currents without the effects of endogenous NO using NOS inhibitors. As shown in Figure 3 , in the presence of L-NAME (1mM), both I o and I i induced by ACh (30 nM) were decreased to two-fifths (175.5 ± 33.5 pQ/s for ACh and 65.6 ± 12.7 for ACh/L-NAME, P<0.05; n=9) and to two-thirds (22.2 ± 3.6 versus 13.5 ± 1.7 pQ/s, P<0.05; n=9) of the pre-L-NAME control values, respectively ( Figure 3A ).
Further, either the removal of L-NAME or the subsequent addition of L-arginine reversibly abolished the inhibitory effect of L-NAME ( Figure 3A , 3B). When L-arginine was introduced on ACh/L-NAME, both I o and I i recovered to the pre L-NAME control values (I o : 83.3 ± 14.9 pQ/s for ACh/L-NAME and 156.1 ± 30.4 for ACh/L-NAME/L-arginine, P<0.05; n=6, I i : 15.0 ± 1.8 versus 27.4 ± 5.8 pQ/s, P<0.05; n=6) ( Figure 3B ). The exogenous NO donor NOC-5 also reversibly abolished the inhibitory effect of L-NAME on the ionic currents (I o : 111.8 ± 28.7 pQ/s for ACh/L-NAME and 147.6 ± 20.6 for ACh/L-NAME/NOC-5, P<0.05; n=7, I i : 32.4 ± 10.0 versus 44.1 Figure 3C ). L-arginine or NOC-5 alone did not raise any electrical response ( Figure 3D , 3E). These findings suggest that the endogenous NO takes part in the generation of ACh-evoked currents and has a potentiating effect on these currents in the presence of physiological doses of ACh.
In the presence of 7-NI (1 mM), both The electrical responses obtained in our present study originated in different sizes of cells. In other words, since each responding cell has different membrane capacitances, for a strict estimation the electrical responses should be compared by the change rate between pre and post introduction of the materials in each cell. Again, the data were compared by estimating the values of the pre L-NAME response as 100% and are summarized in Figure 3F and Figure 4C .
Effects of cGK inhibitors on ACh-induced ionic currents
To assess whether cGK activation is necessary for the ACh-induced ionic currents, we investigated the effects of two different types of membrane permeable cGK inhibitors, KT-5823
and Rp-8-Br-cGMP. KT-5823 has been reported to be a potent cGK I inhibitor only in cell free system and not in intact cells (34) . However, because of some findings described in Discussion,
we believe that KT-5823 works as a specific cGK inhibitor in tracheal gland cells. We think that 1 uM cGK I inhibitors may be sufficient to inhibit cGK I activity in the very delicate ionic responses, without other unexpected effects.
In the presence of KT-5823, both I o and I i induced by ACh decreased to three-fifths 
No effect of NOS inhibitor on ionic currents induced by high dose of ACh
In the case of a high dose (300 nM) of ACh, the response of ionic currents is very large and desensitized before long, compared with that in the case of low dose (30 nM) of ACh ( Figure 6A , 6B). Under this physiologically irrelevant robust stimulation, the inhibitory effect of L-NAME could not be observed, in the case of both pre-and post-treatment with L-NAME ( Figure 6B ).
These findings suggest that NO can potentiate the ionic currents only when cells are moderately stimulated by ACh, but not when the stimulation by ACh is too strong.
Discussion
In the present study, we revealed that endogenous NO has a role in the intracellular signaling pathway involved in tracheal submucosal gland secretion stimulated by a physiologically relevant dose of ACh.
NO imaging experiments revealed that a relatively low concentration of ACh (100 nM stimulated by a high concentration of ACh (300 nM or more), large currents were transiently observed and decreased gradually to the pre ACh levels (26). After such strong stimulation, the cells were desensitized and showed no apparent response for several minutes ( Figure 6B ). Concerning the effect of NO against human airway anion secretions, Duszyk reported that NO by itself could activate transepithelial anion secretion via a cGMP dependent pathway in Calu-3 cells and speculated that cGK activation would cause an activation of both Ca 2+ -activated potassium (Kca) and Ca 2+ -activated chloride (Clca) channels (46). However, our findings showed some differences from his. First, NO by itself did not generate any ionic currents in our study ( Figure 3E ). Second, we revealed that NO has potentiating effects on I o and I i only under the stimulation by a physiologically relevant low dose of ACh, but not in the case of an excessively high dose of ACh. We think these two points are original and essential for our study.
It is widely known that many cells have enough L-arginine in the cytosol (41). We believe that tracheal gland cells also contain enough L-arginine. However, gland cells never generate ionic currents in un-stimulated conditions. Therefore, we think it is reasonable that L-arginine has no effect per se on ACh-induced ionic currents, unless NOS is inhibited. We revealed that NO has potentiating effects on I o and I i under the stimulation by such a low dose of ACh, but not in the case of both an excessive stimulation by high dose of ACh and non-stimulated control condition.
Therefore, we think it is also reasonable that NOC-5 has no effect on ionic currents when cells are not stimulated by ACh. The main purpose of figure 3D and 3E is to show that both L-arginine and NOC-5 do not induce any ionic currents per se, but has an effect to remove the inhibition by L-NAME on ACh-induced ionic currents, as shown in figure 3B and 3C. These points are very important and different from other reports, which described that GSNO or other NO donors induced Cl -secretion from airway epithelial cells (46, 53, 54). We do not have a clear explanation for these discrepancies. But we consider that one possibility may be differences between cultured cells and freshly isolated cells. A major advantage of our study was that we could use freshly isolated tracheal submucosal gland cells and observe the electrical responses stimulated by a physiologically relevant low dose of ACh. In the case of cultured cells, the cells were usually stimulated by a very high dose of agonist to get the maximum responses. We believe that the former responses are more physiological than the latter. But, such considerations are still controversial.
Concerning the intracellular signaling pathways of physiological secretions, the target molecule of cGK phospholylation is still unclear. As mentioned by Duszyk (46), we also speculate that the effects of cGK phospholylation may be to enhance the sensitivity of Kca and Clca against [Ca 2+ ] i (see Figure 7) . In other exocrine glands including pancreas (38), submandibular (39), and parotid glands (31), the same mechanisms appeared to be involved in the effects of NO on secretion. To confirm these speculations further investigations will be needed. We think that one of the intracellular mechanisms of the potentiating effect of NO is a pathway via the activation of cGK, especially cGK I. Vaandrager and coworkers reported that the membrane localization of cGK II was important to activate CFTR in intestinal epithelium, but the soluble type I cGK did not work in the activation of CFTR (55) . It is known that there are two major pathways in the chloride secretion from tracheal submucosal glands. One is characterized by the CFTR chloride channel, which is mainly activated by cAMP, and partially by cGMP. The other is caused by the Ca 2+ -activated chloride channel. In our study, we focused on the latter one only and revealed that cGK I contributes to this pathway. Concerning the involvement of cGK II, it should be further investigated in the future.
In summary, the results of our study suggest that NO/cGMP/cGK signaling is involved in the physiological signaling pathway of airway electrolyte secretion. It is known that NO synthesis is upregulated in the airways in patients with bronchial asthma (56) and downregulated in patients with cystic fibrosis (57) . These findings support the conclusion that an abnormal upregulation of NO may have some influence on the pathophysiology of various chronic hypersecretory airway diseases, including chronic bronchitis or bronchial asthma, whereas the downregulation of NO may contribute to dehydration of the airway surface liquid in chronic airway infectious diseases such as cystic fibrosis (4). Representative traces showing the effects of NOS inhibitors on endogenous NO synthesis.
(A) L-NAME (1 mM), a competitive NOS inhibitor, inhibited the ACh-mediated NO synthesis.
The fluorescence intensities were elevated after the subsequent addition of L-arginine. 22 (B) 7-NI (1 mM), a specific inhibitor of nNOS, also inhibited the ACh-mediated NO synthesis, which was recovered by the subsequent addition of L-arginine. (A) L-NAME (1 mM) partially inhibited the ACh-induced ionic currents. After the removal of L-NAME, the ionic response recovered to the pre inhibitory levels.
(B) This inhibitory effect was also reversibly abolished after the subsequent addition of L-arginine (1 mM).
(C) An exogenous NO donor, NOC-5 (100 µM), also reversibly abolished the inhibitory effect of L-NAME on the ionic currents.
(D) L-arginine (1 mM) alone did not cause any ionic responses. Because the subsequent addition of ACh generated ionic currents in the same cell, it is considered that the cell viability was conserved.
(E) NOC-5 (100 µM) also caused no ionic response from un-stimulated cells, which generated ionic currents after the subsequent addition of ACh.
(F) Summary of the inhibitory effects of L-NAME on ACh-induced I o and I i currents. The electric charge movements of 20 s duration just before and after introducing L-NAME or other agents were compared by estimating the mean values of the L-NAME responses as 100%, to exclude the artifacts from the scattering of the membrane capacitance in each cell.
L-NAME significantly inhibited both I o and I i . * P<0.05. Representative original recordings showing no effect of L-NAME on the high dose ACh-induced ionic currents.
(A) When cells were stimulated by 30 nM of ACh, the cells usually generated oscillatory currents imposed on sustained currents in I o and I i during the stimulation.
(B) A robust stimulation by high dose (300 nM) of ACh generated large and transient currents and desensitization even in the presence of ACh. L-NAME (1 mM) had no apparent inhibitory effect on these large currents, as in the case of pretreatment with L-NAME.
(C) Summary of the effects of L-NAME on I o in the presence of 300 nM of ACh. L-NAME (1 mM) did not inhibit the ionic currents raised by 300 nM of ACh, in contrast to what was observed in the case of 30 nM of ACh (Figure 3 ). 
